The Supreme Court has decided not to expedite a legal challenge concerning tariffs imposed by President Donald Trump. This ...

Despite former President Donald Trump’s threat of a 200% tariff on imported drugs during a cabinet meeting, pharmaceutical investors have shown surprisingly positive sentiment this week. Despite ...

Small and medium-sized firms like Mitsuwa Electric that form the backbone of Japan's economy have weathered many storms over ...

President Trump has nominated Dr. Julie Callahan for the role as Chief Agricultural Negotiator for the U.S. Trade Representative’s office (USTR). Callahan, who serves as Assistant U.S. Trade ...

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.

Novartis AG beats Q2 2025 expectations, but patent expiries and policy risks loom. Click for my updated look at NVS earnings ...

President Donald Trump has dialed down his confrontational tone with China in an effort to secure a summit with counterpart Xi Jinping and a trade deal with the world’s second-largest economy, people ...

“Almost every one of them said I should,” Trump said today. However, the president emphasized to reporters, he had no immediate plans to dismiss Powell. Still, Trump added a caveat: The Fed chair ...

J&J reported second quarter earnings Tuesday. The company is under scrutiny by investors as it faces drug patent cliffs.

Deutsche Bank strategist Henry Allen said for the fourth straight year, markets are complacent over inflation, but tariffs are making that a dangerous viewpoint right now.

House deals a blow to “Crypto Week,” ASML warns on 2026 growth, a promising Chinese weight-loss drug, and more news to start your day.

President Donald Trump and Sen. David McCormick of Pennsylvania have jointly announced tens of billions of dollars of energy ...